| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/01/2013 | EP2585011A2 Intravaginal devices comprising anticholinergic agents, and methods of making thereof |
| 05/01/2013 | EP2585010A2 Methods of treating conditions associated with overactive bladder |
| 05/01/2013 | EP2584919A1 Prebiotic effect of galactofructose |
| 05/01/2013 | EP2584913A1 Stabilized active compound |
| 05/01/2013 | EP2584901A1 A process for etra virine intermediate and polymorphs of etravirine |
| 05/01/2013 | EP2584900A1 Combination therapy with cryosurgery and low dosage strength imiquimod to treat actinic keratosis |
| 05/01/2013 | EP2584899A1 Niacin mimetics, and methods of use thereof |
| 05/01/2013 | EP2584897A1 Resveratrol-containing compositions and methods of use |
| 05/01/2013 | EP2396430B1 Template-independent ligation of single-stranded dna |
| 05/01/2013 | EP2318390B1 Pyrrole compounds |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
| 05/01/2013 | CN202909135U Medicine patch for curing foot calluses, cleft hands and cleft feet |
| 05/01/2013 | CN1564682B Compositions for potentiating glutatthione |
| 05/01/2013 | CN103080334A Micro-RNA biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma |
| 05/01/2013 | CN103080314A Inhibitor of expression of dominantly mutated gene |
| 05/01/2013 | CN103080238A Process for the manufacture of a highly enriched extract containing zeaxanthin and/or its esters |
| 05/01/2013 | CN103080124A Process for production of triterpene alcohol |
| 05/01/2013 | CN103080113A 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| 05/01/2013 | CN103080112A Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN103080111A Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN103080109A Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 05/01/2013 | CN103080107A Heteroaryl compounds and compositions as protein kinase inhibitors |
| 05/01/2013 | CN103080106A Cyclic ether compounds useful as kinase inhibitors |
| 05/01/2013 | CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 05/01/2013 | CN103080103A Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
| 05/01/2013 | CN103080101A Piperidinyl-substituted lactams as GPR119 modulators |
| 05/01/2013 | CN103080100A Method for producing 1-triazole-2-butanol derivative |
| 05/01/2013 | CN103080096A Bisaryl (thio)morpholine derivatives as S1P modulators |
| 05/01/2013 | CN103080095A Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 05/01/2013 | CN103080094A P2X4 receptor antagonist |
| 05/01/2013 | CN103080093A Indazole compounds and their uses |
| 05/01/2013 | CN103080092A Pyrazolo-quinolines |
| 05/01/2013 | CN103080090A Anti-inflammatory agents |
| 05/01/2013 | CN103080089A 5-HT2B receptor antagonists |
| 05/01/2013 | CN103080088A Production method of intermediate compound for synthesizing medicament |
| 05/01/2013 | CN103080086A Prostaglandin D synthase inhibitory piperidine compounds |
| 05/01/2013 | CN103080085A Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1H-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid |
| 05/01/2013 | CN103080083A Process for the preparation of pleuromutilins |
| 05/01/2013 | CN103080080A 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments |
| 05/01/2013 | CN103080079A Phenylcarbamate compound and muscle relaxant containing the same |
| 05/01/2013 | CN103080073A (2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals |
| 05/01/2013 | CN103080063A Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament |
| 05/01/2013 | CN103079595A Aqueous composition for ophthalmic administration |
| 05/01/2013 | CN103079583A Use of a fermented soy extract for manufacture of a prebiotic composition |
| 05/01/2013 | CN103079575A Laxative containing polyethylene glycol and electrolytes |
| 05/01/2013 | CN103079574A Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| 05/01/2013 | CN103079573A A method for preparation of highly pure asiaticoside composition from centella asiatica and a method of use thereof |
| 05/01/2013 | CN103079572A Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases |
| 05/01/2013 | CN103079571A Noribogaine compositions |
| 05/01/2013 | CN103079570A Aryl and heteroaryl sulfones as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/01/2013 | CN103079569A Pharmaceutical compositions containing vanoxerine |
| 05/01/2013 | CN103079568A New drug combinations for the treatment of malaria |
| 05/01/2013 | CN103079567A Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions |
| 05/01/2013 | CN103079566A Heterocyclyl compounds as histamine H3 receptor ligands |
| 05/01/2013 | CN103079565A Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/01/2013 | CN103079564A Therapeutic agent for pain |
| 05/01/2013 | CN103079563A Proline sulfonamide derivatives as orexin receptor antagonists |
| 05/01/2013 | CN103079562A BACE inhibitors for use in the treatment of diabetes |
| 05/01/2013 | CN103079561A Topical antiviral formulations for prevention of transmission of HSV-2 |
| 05/01/2013 | CN103079559A Formulations including amiodarone and salts thereof and methods of their manufacture and use |
| 05/01/2013 | CN103079558A IRE-1[alpha] inhibitors |
| 05/01/2013 | CN103079557A Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 05/01/2013 | CN103079556A Pharmaceutical composition for the prevention or treatment of degenerative neurological brain disorders |
| 05/01/2013 | CN103079555A Triheptanoin diet for adult polyglucosan body disease (APBD) treatment |
| 05/01/2013 | CN103079554A Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| 05/01/2013 | CN103079553A N-acyl amino acid derivatives for treating skin conditions such as cellulite |
| 05/01/2013 | CN103079552A Topical pharmaceutical composition comprising flurbiprofen |
| 05/01/2013 | CN103079551A Combination of HDAC inhibitors with thrombocytopenia drugs |
| 05/01/2013 | CN103079550A N-acetyl-DL-leucine, neuroprotective and retinoprotective medicament |
| 05/01/2013 | CN103079548A Pharmaceutical dosage form comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 05/01/2013 | CN103079547A Process for producing drug-block-copolymer composite and pharmaceutical product containing same |
| 05/01/2013 | CN103079544A Injectable flowable composition comprising buprenorphine |
| 05/01/2013 | CN103079415A Nutritional composition for the stimulation of muscle protein synthesis |
| 05/01/2013 | CN103073653A Biological enzymatic hydrolysis extraction method of coronary disease relieving component |
| 05/01/2013 | CN103073650A Red stilbene polysaccharide 4 and effective component preparation and application |
| 05/01/2013 | CN103073615A Oleanolic acid kushenin compound salt and preparation method thereof |
| 05/01/2013 | CN103073608A Androstane-4, 6, 8 (9), 13 (14)-tetraene-3, 11, 16-triketone and application thereof |
| 05/01/2013 | CN103073607A 12[beta]-hydroxyandrostane-4,6,8(9),13(14)-tetraene-3,11,16-triketone and application thereof |
| 05/01/2013 | CN103073562A Method for refining cefamandole nafate, cefamandole nafate and application thereof |
| 05/01/2013 | CN103073560A Sauchinone derivative and preparing method and application thereof |
| 05/01/2013 | CN103073557A Benzophenanthridine alkaloid and application of benzophenanthridine alkaloid in resisting cardiovascular system diseases |
| 05/01/2013 | CN103073543A Preparation method and application of tropisetron citrate crystal form I |
| 05/01/2013 | CN103073542A Preparation method and application of tropisetron citrate crystal form II |
| 05/01/2013 | CN103073539A 4-(substituted phenylamino)quinazoline derivative, and preparation method, pharmaceutical composition and application thereof |
| 05/01/2013 | CN103073529A 2-furoacridone-beta-dihydroagarofuran sesquiterpene compound in leafy parnassia, and preparation method and application thereof |
| 05/01/2013 | CN103073508A Kinase inhibitor and method for treating related diseases |
| 05/01/2013 | CN103073501A Ornidazole crystal compound |
| 05/01/2013 | CN103073486A Polymorphs of N-(6-(4-chlorophenyloxy)hexyl)-N'-cyano-N"-(4-pyridyl)guanidine, and preparation methods and applications thereof |
| 05/01/2013 | CN103073460A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 05/01/2013 | CN103073455A Novel KCNQ potassium channel agonist, and preparation method and application thereof |
| 05/01/2013 | CN103073451A Histone deacetylase inhibitor |
| 05/01/2013 | CN103073450A Solid forms of selective androgen receptor modulators |
| 05/01/2013 | CN103073448A Polyamine derivative having aromatic ring structure, as well as preparation method and application thereof |
| 05/01/2013 | CN103071154A Combination anticoagulant therapy with a compound that acts as a factor XA inhibitor |
| 05/01/2013 | CN103071150A Chinese patent medicine for treating Alzheimer's disease |
| 05/01/2013 | CN103071149A Collagen and squalane composition, preparations thereof, and preparation methods and applications of composition and preparations |
| 05/01/2013 | CN103071148A Compound thymosin Alpha 1 injection for improving livability of piglet and preparation method |
| 05/01/2013 | CN103071145A N(2)-L-alanyl-L-glutamine/compound amino acid injection (18AA-V) pharmaceutical composite preparation |
| 05/01/2013 | CN103071142A Quick-acting external patch for tracheitis |
| 05/01/2013 | CN103071139A Combined crude herb moxibustion medicines for warming Yang to dispel cold and warming and activating meridians and collaterals and preparation method thereof |